A recent study showed that the specific targeting of TGFβ signaling in CD4 T cells, via a TGFBR2 coupled to a CD4 antibody induces an anti-tumor response mediated by IL-4 in a mouse breast cancer model [54]. Here, TGFB1 is linked to neoplasm.